Your trusted source for GLP-1 research, news, and patient insights.
7 posts in this category
Worried about “Ozempic personality”? The FDA’s 2026 review of 107,910 patients tells a more reassuring story than the headlines do.
Food noise is the constant background chatter about food some people live with. Here is what it is, what science shows, and why GLP-1s revealed it.
A plain-language look at what the research shows about GLP-1 weight loss, divorce rates, and how relationships really change on the medication.
64% of Americans say GLP-1 drugs hurt body positivity. Here's what research says about body image, Ozempic face, and making health decisions.
New research links semaglutide to 42% fewer psychiatric hospitalizations. See what studies show about GLP-1 medications, depression, and anxiety.
New research links GLP-1 medications to reduced addiction risk. See what the WashU and JAMA studies found and what clinical trials are underway.
GLP-1s may calm food noise and support focus, but they’re not brain boosters. Learn what science says about energy, cravings, and side effects.
